Allergan Gets a Lift on Analyst Buzz

Now, AGN is pacing for its fifth straight win

Digital Content Manager
Jan 4, 2019 at 1:43 PM
facebook twitter linkedin


Allergan plc (NYSE:AGN) stock is attempting a comeback today, after a Mizuho Securities analyst said the stock was undervalued -- calling it "very salvageable and cheap." AGN stock took a recent hit after the recall of its textured breast implants in Europe, resulting in a five-year low of $125.84 on Dec. 26.

Today, though, AGN is pacing for its fifth straight win, with shares up 4.5% at $142.22, at last check. The Botox concern is now set to close back atop its 20-day moving average, a trendline it hasn't conquered since shortly after its October highs.

AGN since July 2018

Analysts are generally optimistic about Allergan stock, with 12 giving the security a "buy" or better rating, compared to five issuing "holds." What's more, the current consensus 12-month price target -- a lofty $207.11 per share -- represents expected upside of roughly 45% to current levels.

Options traders have a sunny outlook on AGN, too. Currently, the stock is sporting a Schaeffer's put/call open interest (SOIR) of 0.59 that sits in just the 4th percentile of its annual range. This suggests that short-term traders have rarely been more call-heavy in the past 12 months.

 
 

 

 

These investors are using the market's volatility to their advantage and scoring triple-digit gains on many of their trades.

Even in today's sideways bear market, this trading strategy has continued to provide consistency and profitability to a small group of investors. By using this approach, these traders are removing directional risk and still hitting triple-digit returns. If you want access to this strategy, and lower risk with higher returns sounds good to you, then don't wait another minute.

Join us now to receive our next trades the moment they come out!

 

Common mistakes options traders make
 


 


 
Special Offers from Schaeffer's Trading Partners